DM

Devesh Malladi

Active Director Managing Director DIN 00025221
DIN 00025221 First appointment Nov 1998 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 7 active board seats
Past companies 8 historical roles
Total affiliations 15 Since Nov 1998
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 24 Nov 1998
Active appointments 13
Total timeline records 15

Devesh Malladi (DIN 00025221) has 15 recorded board appointments in Indian companies, the first from November 1998, of which 13 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1998
Jsr Advisory Llp Designated Partner · 2025 – present
Current
Medrenova Private Limited Additional Director · 2024 – present
Current
Flint Management Consultants Llp Partner · 2021 – present
Current
Prerna Industries Llp Designated Partner · 2019 – present
Current
Spera Advisory Llp Designated Partner · 2018 – present
Current
Arco Iris Consultants Llp Designated Partner · 2012 – present
Current
Embio Limited Managing Director · 2007 – present
Current
Injen Rx Pharma Limited Director · 2005 – present
Current
Malladi Industries Private Limited Director · 2004 – present
Current
Hakuna Farma Private Limited Director · 1999 – present
Current
Malladi Investments Private Limited Director · 1998 – present
Current
Guru Narayan Fincap Private Limited Director · 1998 – present
Current
Urav Consultancy Private Limited Director · 1998 – present
Current
Rik Technologies India Private Limited Director · 2009 – 2013
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available